nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—Acetazolamide—epilepsy syndrome	0.448	1	CrCtD
Methazolamide—CA4—epilepsy syndrome	0.0948	0.632	CbGaD
Methazolamide—CYP2C19—epilepsy syndrome	0.0317	0.212	CbGaD
Methazolamide—CYP2D6—epilepsy syndrome	0.0235	0.157	CbGaD
Methazolamide—CA14—Lacosamide—epilepsy syndrome	0.0122	0.042	CbGbCtD
Methazolamide—CA6—Lacosamide—epilepsy syndrome	0.0116	0.0398	CbGbCtD
Methazolamide—CA5B—Lacosamide—epilepsy syndrome	0.0101	0.0347	CbGbCtD
Methazolamide—CA9—Lacosamide—epilepsy syndrome	0.0087	0.0298	CbGbCtD
Methazolamide—CA14—Acetazolamide—epilepsy syndrome	0.00843	0.0289	CbGbCtD
Methazolamide—CA1—Lacosamide—epilepsy syndrome	0.00814	0.0279	CbGbCtD
Methazolamide—CA5A—Acetazolamide—epilepsy syndrome	0.008	0.0274	CbGbCtD
Methazolamide—CA6—Acetazolamide—epilepsy syndrome	0.008	0.0274	CbGbCtD
Methazolamide—CA14—Zonisamide—epilepsy syndrome	0.0078	0.0267	CbGbCtD
Methazolamide—CA4—Lacosamide—epilepsy syndrome	0.00765	0.0262	CbGbCtD
Methazolamide—CA5A—Zonisamide—epilepsy syndrome	0.00741	0.0254	CbGbCtD
Methazolamide—CA6—Zonisamide—epilepsy syndrome	0.00741	0.0254	CbGbCtD
Methazolamide—CA2—Lacosamide—epilepsy syndrome	0.00703	0.0241	CbGbCtD
Methazolamide—CA7—Acetazolamide—epilepsy syndrome	0.00698	0.0239	CbGbCtD
Methazolamide—CA5B—Acetazolamide—epilepsy syndrome	0.00698	0.0239	CbGbCtD
Methazolamide—CA5B—Zonisamide—epilepsy syndrome	0.00645	0.0221	CbGbCtD
Methazolamide—CA7—Zonisamide—epilepsy syndrome	0.00645	0.0221	CbGbCtD
Methazolamide—CA9—Acetazolamide—epilepsy syndrome	0.00599	0.0205	CbGbCtD
Methazolamide—CA12—Acetazolamide—epilepsy syndrome	0.00599	0.0205	CbGbCtD
Methazolamide—CA1—Acetazolamide—epilepsy syndrome	0.0056	0.0192	CbGbCtD
Methazolamide—CA9—Zonisamide—epilepsy syndrome	0.00554	0.019	CbGbCtD
Methazolamide—CA12—Zonisamide—epilepsy syndrome	0.00554	0.019	CbGbCtD
Methazolamide—CA6—Topiramate—epilepsy syndrome	0.0054	0.0185	CbGbCtD
Methazolamide—CA5A—Topiramate—epilepsy syndrome	0.0054	0.0185	CbGbCtD
Methazolamide—CA4—Acetazolamide—epilepsy syndrome	0.00527	0.018	CbGbCtD
Methazolamide—CA1—Zonisamide—epilepsy syndrome	0.00518	0.0178	CbGbCtD
Methazolamide—CA4—Zonisamide—epilepsy syndrome	0.00487	0.0167	CbGbCtD
Methazolamide—CA2—Acetazolamide—epilepsy syndrome	0.00484	0.0166	CbGbCtD
Methazolamide—CA7—Topiramate—epilepsy syndrome	0.0047	0.0161	CbGbCtD
Methazolamide—CA5B—Topiramate—epilepsy syndrome	0.0047	0.0161	CbGbCtD
Methazolamide—CA2—Zonisamide—epilepsy syndrome	0.00448	0.0153	CbGbCtD
Methazolamide—CA9—Topiramate—epilepsy syndrome	0.00404	0.0138	CbGbCtD
Methazolamide—CA12—Topiramate—epilepsy syndrome	0.00404	0.0138	CbGbCtD
Methazolamide—CA1—Topiramate—epilepsy syndrome	0.00378	0.0129	CbGbCtD
Methazolamide—CA4—Topiramate—epilepsy syndrome	0.00355	0.0122	CbGbCtD
Methazolamide—CA2—Topiramate—epilepsy syndrome	0.00326	0.0112	CbGbCtD
Methazolamide—CYP2E1—Felbamate—epilepsy syndrome	0.00304	0.0104	CbGbCtD
Methazolamide—CYP2E1—Trimethadione—epilepsy syndrome	0.00304	0.0104	CbGbCtD
Methazolamide—CYP2E1—Clonazepam—epilepsy syndrome	0.00258	0.00885	CbGbCtD
Methazolamide—CYP2E1—Rufinamide—epilepsy syndrome	0.00211	0.00722	CbGbCtD
Methazolamide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00205	0.00702	CbGbCtD
Methazolamide—CYP2C19—Felbamate—epilepsy syndrome	0.0019	0.00652	CbGbCtD
Methazolamide—CYP2C19—Trimethadione—epilepsy syndrome	0.0019	0.00652	CbGbCtD
Methazolamide—SLC22A6—Acetazolamide—epilepsy syndrome	0.00186	0.00638	CbGbCtD
Methazolamide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00179	0.00613	CbGbCtD
Methazolamide—CYP2E1—Propofol—epilepsy syndrome	0.00172	0.00588	CbGbCtD
Methazolamide—CYP2E1—Phenobarbital—epilepsy syndrome	0.00164	0.00562	CbGbCtD
Methazolamide—CYP2E1—Midazolam—epilepsy syndrome	0.00162	0.00554	CbGbCtD
Methazolamide—CYP2C9—Trimethadione—epilepsy syndrome	0.00158	0.00542	CbGbCtD
Methazolamide—CYP2E1—Diazepam—epilepsy syndrome	0.00156	0.00533	CbGbCtD
Methazolamide—CYP2C19—Clobazam—epilepsy syndrome	0.00155	0.00532	CbGbCtD
Methazolamide—CA6—ear—epilepsy syndrome	0.00151	0.138	CbGeAlD
Methazolamide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00149	0.0051	CbGbCtD
Methazolamide—Acetazolamide—AQP1—epilepsy syndrome	0.00145	0.739	CrCbGaD
Methazolamide—SLC22A6—Valproic Acid—epilepsy syndrome	0.00139	0.00477	CbGbCtD
Methazolamide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00129	0.00441	CbGbCtD
Methazolamide—CYP2C19—Primidone—epilepsy syndrome	0.0012	0.00411	CbGbCtD
Methazolamide—CYP2C19—Phenytoin—epilepsy syndrome	0.00115	0.00395	CbGbCtD
Methazolamide—CYP2C19—Propofol—epilepsy syndrome	0.00108	0.00369	CbGbCtD
Methazolamide—CYP2C9—Carbamazepine—epilepsy syndrome	0.00107	0.00366	CbGbCtD
Methazolamide—CYP2C19—Phenobarbital—epilepsy syndrome	0.00103	0.00352	CbGbCtD
Methazolamide—CYP2C9—Primidone—epilepsy syndrome	0.000998	0.00342	CbGbCtD
Methazolamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00099	0.00339	CbGbCtD
Methazolamide—CYP2C19—Diazepam—epilepsy syndrome	0.000975	0.00334	CbGbCtD
Methazolamide—CYP2C9—Phenytoin—epilepsy syndrome	0.000959	0.00329	CbGbCtD
Methazolamide—CYP2C19—Zonisamide—epilepsy syndrome	0.000952	0.00326	CbGbCtD
Methazolamide—CYP3A4—Trimethadione—epilepsy syndrome	0.000921	0.00315	CbGbCtD
Methazolamide—CYP3A4—Felbamate—epilepsy syndrome	0.000921	0.00315	CbGbCtD
Methazolamide—CYP2C9—Propofol—epilepsy syndrome	0.000895	0.00307	CbGbCtD
Methazolamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.000866	0.00297	CbGbCtD
Methazolamide—CYP2C9—Phenobarbital—epilepsy syndrome	0.000855	0.00293	CbGbCtD
Methazolamide—CYP2D6—Propofol—epilepsy syndrome	0.000818	0.0028	CbGbCtD
Methazolamide—CYP2C9—Diazepam—epilepsy syndrome	0.000811	0.00278	CbGbCtD
Methazolamide—CYP3A4—Clonazepam—epilepsy syndrome	0.000783	0.00268	CbGbCtD
Methazolamide—CYP2C19—Valproic Acid—epilepsy syndrome	0.000769	0.00263	CbGbCtD
Methazolamide—CYP3A4—Clobazam—epilepsy syndrome	0.000751	0.00257	CbGbCtD
Methazolamide—CYP2C19—Topiramate—epilepsy syndrome	0.000693	0.00238	CbGbCtD
Methazolamide—CYP2C9—Valproic Acid—epilepsy syndrome	0.000639	0.00219	CbGbCtD
Methazolamide—CYP3A4—Rufinamide—epilepsy syndrome	0.000638	0.00219	CbGbCtD
Methazolamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.000622	0.00213	CbGbCtD
Methazolamide—CYP3A4—Primidone—epilepsy syndrome	0.000581	0.00199	CbGbCtD
Methazolamide—CYP3A4—Phenytoin—epilepsy syndrome	0.000558	0.00191	CbGbCtD
Methazolamide—CYP3A4—Propofol—epilepsy syndrome	0.00052	0.00178	CbGbCtD
Methazolamide—Acetazolamide—CA4—epilepsy syndrome	0.000514	0.261	CrCbGaD
Methazolamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.000497	0.0017	CbGbCtD
Methazolamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.000497	0.0017	CbGbCtD
Methazolamide—CYP3A4—Midazolam—epilepsy syndrome	0.00049	0.00168	CbGbCtD
Methazolamide—CYP3A4—Diazepam—epilepsy syndrome	0.000471	0.00161	CbGbCtD
Methazolamide—CYP3A4—Zonisamide—epilepsy syndrome	0.00046	0.00158	CbGbCtD
Methazolamide—CA4—ganglion—epilepsy syndrome	0.00039	0.0356	CbGeAlD
Methazolamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.000372	0.00127	CbGbCtD
Methazolamide—CYP3A4—Topiramate—epilepsy syndrome	0.000335	0.00115	CbGbCtD
Methazolamide—CA14—telencephalon—epilepsy syndrome	0.000311	0.0285	CbGeAlD
Methazolamide—CA4—hindbrain—epilepsy syndrome	0.000296	0.027	CbGeAlD
Methazolamide—CA7—midbrain—epilepsy syndrome	0.000268	0.0245	CbGeAlD
Methazolamide—CA12—forebrain—epilepsy syndrome	0.000264	0.0241	CbGeAlD
Methazolamide—CA2—hindbrain—epilepsy syndrome	0.000245	0.0224	CbGeAlD
Methazolamide—CA14—medulla oblongata—epilepsy syndrome	0.000245	0.0224	CbGeAlD
Methazolamide—CA12—telencephalon—epilepsy syndrome	0.000243	0.0222	CbGeAlD
Methazolamide—CA6—head—epilepsy syndrome	0.000225	0.0206	CbGeAlD
Methazolamide—CA14—midbrain—epilepsy syndrome	0.000224	0.0204	CbGeAlD
Methazolamide—CA14—spinal cord—epilepsy syndrome	0.000218	0.0199	CbGeAlD
Methazolamide—CA1—forebrain—epilepsy syndrome	0.000209	0.0191	CbGeAlD
Methazolamide—CA7—cerebellum—epilepsy syndrome	0.000208	0.019	CbGeAlD
Methazolamide—CA1—telencephalon—epilepsy syndrome	0.000192	0.0176	CbGeAlD
Methazolamide—CA9—cerebellum—epilepsy syndrome	0.000182	0.0167	CbGeAlD
Methazolamide—CA14—cerebellum—epilepsy syndrome	0.000173	0.0158	CbGeAlD
Methazolamide—CA4—brainstem—epilepsy syndrome	0.000169	0.0155	CbGeAlD
Methazolamide—CA7—brain—epilepsy syndrome	0.000169	0.0154	CbGeAlD
Methazolamide—CA4—forebrain—epilepsy syndrome	0.000163	0.015	CbGeAlD
Methazolamide—CYP2D6—hindbrain—epilepsy syndrome	0.000156	0.0142	CbGeAlD
Methazolamide—CA12—head—epilepsy syndrome	0.000151	0.0138	CbGeAlD
Methazolamide—CA4—telencephalon—epilepsy syndrome	0.00015	0.0137	CbGeAlD
Methazolamide—CA12—nervous system—epilepsy syndrome	0.000143	0.0131	CbGeAlD
Methazolamide—CA14—brain—epilepsy syndrome	0.00014	0.0128	CbGeAlD
Methazolamide—CA2—brainstem—epilepsy syndrome	0.00014	0.0128	CbGeAlD
Methazolamide—CA12—central nervous system—epilepsy syndrome	0.000138	0.0126	CbGeAlD
Methazolamide—CA5B—head—epilepsy syndrome	0.000136	0.0124	CbGeAlD
Methazolamide—CA2—forebrain—epilepsy syndrome	0.000136	0.0124	CbGeAlD
Methazolamide—CA1—spinal cord—epilepsy syndrome	0.000135	0.0123	CbGeAlD
Methazolamide—CA5B—nervous system—epilepsy syndrome	0.000129	0.0118	CbGeAlD
Methazolamide—CA2—telencephalon—epilepsy syndrome	0.000125	0.0114	CbGeAlD
Methazolamide—CA5B—central nervous system—epilepsy syndrome	0.000124	0.0113	CbGeAlD
Methazolamide—SLC22A6—brain—epilepsy syndrome	0.000122	0.0112	CbGeAlD
Methazolamide—CA1—head—epilepsy syndrome	0.00012	0.011	CbGeAlD
Methazolamide—CA4—medulla oblongata—epilepsy syndrome	0.000118	0.0108	CbGeAlD
Methazolamide—CA1—nervous system—epilepsy syndrome	0.000114	0.0104	CbGeAlD
Methazolamide—CA12—brain—epilepsy syndrome	0.00011	0.01	CbGeAlD
Methazolamide—CA1—central nervous system—epilepsy syndrome	0.000109	0.01	CbGeAlD
Methazolamide—CA4—midbrain—epilepsy syndrome	0.000108	0.00987	CbGeAlD
Methazolamide—CA4—spinal cord—epilepsy syndrome	0.000105	0.00963	CbGeAlD
Methazolamide—CYP2E1—telencephalon—epilepsy syndrome	9.99e-05	0.00914	CbGeAlD
Methazolamide—CA5B—brain—epilepsy syndrome	9.83e-05	0.00899	CbGeAlD
Methazolamide—CA2—medulla oblongata—epilepsy syndrome	9.79e-05	0.00896	CbGeAlD
Methazolamide—CA4—head—epilepsy syndrome	9.36e-05	0.00856	CbGeAlD
Methazolamide—CA2—midbrain—epilepsy syndrome	8.95e-05	0.00819	CbGeAlD
Methazolamide—CYP2D6—brainstem—epilepsy syndrome	8.92e-05	0.00816	CbGeAlD
Methazolamide—CA4—nervous system—epilepsy syndrome	8.87e-05	0.00812	CbGeAlD
Methazolamide—CA2—spinal cord—epilepsy syndrome	8.73e-05	0.00799	CbGeAlD
Methazolamide—CA1—brain—epilepsy syndrome	8.68e-05	0.00794	CbGeAlD
Methazolamide—CYP2D6—forebrain—epilepsy syndrome	8.6e-05	0.00787	CbGeAlD
Methazolamide—CA4—central nervous system—epilepsy syndrome	8.54e-05	0.00781	CbGeAlD
Methazolamide—CA4—cerebellum—epilepsy syndrome	8.35e-05	0.00764	CbGeAlD
Methazolamide—CYP2D6—telencephalon—epilepsy syndrome	7.91e-05	0.00724	CbGeAlD
Methazolamide—CYP2E1—medulla oblongata—epilepsy syndrome	7.85e-05	0.00718	CbGeAlD
Methazolamide—CA2—head—epilepsy syndrome	7.76e-05	0.0071	CbGeAlD
Methazolamide—CA2—nervous system—epilepsy syndrome	7.36e-05	0.00673	CbGeAlD
Methazolamide—CA2—central nervous system—epilepsy syndrome	7.08e-05	0.00648	CbGeAlD
Methazolamide—CYP2E1—spinal cord—epilepsy syndrome	7e-05	0.0064	CbGeAlD
Methazolamide—CA2—cerebellum—epilepsy syndrome	6.92e-05	0.00633	CbGeAlD
Methazolamide—CA4—brain—epilepsy syndrome	6.78e-05	0.0062	CbGeAlD
Methazolamide—CYP2E1—head—epilepsy syndrome	6.22e-05	0.00569	CbGeAlD
Methazolamide—CYP2E1—nervous system—epilepsy syndrome	5.9e-05	0.0054	CbGeAlD
Methazolamide—CYP2E1—central nervous system—epilepsy syndrome	5.68e-05	0.0052	CbGeAlD
Methazolamide—CA2—brain—epilepsy syndrome	5.62e-05	0.00514	CbGeAlD
Methazolamide—CYP2E1—cerebellum—epilepsy syndrome	5.55e-05	0.00508	CbGeAlD
Methazolamide—CYP2D6—head—epilepsy syndrome	4.93e-05	0.00451	CbGeAlD
Methazolamide—CYP3A4—nervous system—epilepsy syndrome	4.75e-05	0.00434	CbGeAlD
Methazolamide—CYP2D6—nervous system—epilepsy syndrome	4.67e-05	0.00427	CbGeAlD
Methazolamide—CYP3A4—central nervous system—epilepsy syndrome	4.57e-05	0.00418	CbGeAlD
Methazolamide—CYP2E1—brain—epilepsy syndrome	4.51e-05	0.00412	CbGeAlD
Methazolamide—CYP2D6—central nervous system—epilepsy syndrome	4.5e-05	0.00411	CbGeAlD
Methazolamide—Erythema multiforme—Pregabalin—epilepsy syndrome	4.46e-05	0.000734	CcSEcCtD
Methazolamide—Dyspepsia—Phenytoin—epilepsy syndrome	4.45e-05	0.000733	CcSEcCtD
Methazolamide—Dysgeusia—Valproic Acid—epilepsy syndrome	4.45e-05	0.000732	CcSEcCtD
Methazolamide—Feeling abnormal—Felbamate—epilepsy syndrome	4.45e-05	0.000732	CcSEcCtD
Methazolamide—Anorexia—Lamotrigine—epilepsy syndrome	4.45e-05	0.000732	CcSEcCtD
Methazolamide—Urticaria—Diazepam—epilepsy syndrome	4.43e-05	0.000729	CcSEcCtD
Methazolamide—Dyspepsia—Oxcarbazepine—epilepsy syndrome	4.43e-05	0.000729	CcSEcCtD
Methazolamide—Decreased appetite—Clonazepam—epilepsy syndrome	4.42e-05	0.000728	CcSEcCtD
Methazolamide—Tinnitus—Pregabalin—epilepsy syndrome	4.4e-05	0.000724	CcSEcCtD
Methazolamide—CYP2D6—cerebellum—epilepsy syndrome	4.4e-05	0.00402	CbGeAlD
Methazolamide—Decreased appetite—Phenytoin—epilepsy syndrome	4.4e-05	0.000724	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	4.39e-05	0.000723	CcSEcCtD
Methazolamide—Fatigue—Clonazepam—epilepsy syndrome	4.39e-05	0.000722	CcSEcCtD
Methazolamide—Asthenia—Midazolam—epilepsy syndrome	4.37e-05	0.00072	CcSEcCtD
Methazolamide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	4.37e-05	0.00072	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	4.36e-05	0.000719	CcSEcCtD
Methazolamide—Fatigue—Phenytoin—epilepsy syndrome	4.36e-05	0.000718	CcSEcCtD
Methazolamide—Feeling abnormal—Zonisamide—epilepsy syndrome	4.35e-05	0.000717	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	4.34e-05	0.000715	CcSEcCtD
Methazolamide—Fatigue—Oxcarbazepine—epilepsy syndrome	4.34e-05	0.000714	CcSEcCtD
Methazolamide—Paraesthesia—Carbamazepine—epilepsy syndrome	4.33e-05	0.000713	CcSEcCtD
Methazolamide—Asthenia—Levetiracetam—epilepsy syndrome	4.32e-05	0.000711	CcSEcCtD
Methazolamide—Pancytopenia—Topiramate—epilepsy syndrome	4.32e-05	0.000711	CcSEcCtD
Methazolamide—Somnolence—Carbamazepine—epilepsy syndrome	4.29e-05	0.000706	CcSEcCtD
Methazolamide—Urticaria—Felbamate—epilepsy syndrome	4.29e-05	0.000706	CcSEcCtD
Methazolamide—Body temperature increased—Felbamate—epilepsy syndrome	4.27e-05	0.000702	CcSEcCtD
Methazolamide—Vomiting—Acetazolamide—epilepsy syndrome	4.26e-05	0.000702	CcSEcCtD
Methazolamide—Diarrhoea—Propofol—epilepsy syndrome	4.26e-05	0.000702	CcSEcCtD
Methazolamide—Dyspepsia—Carbamazepine—epilepsy syndrome	4.25e-05	0.000699	CcSEcCtD
Methazolamide—Ill-defined disorder—Valproic Acid—epilepsy syndrome	4.21e-05	0.000694	CcSEcCtD
Methazolamide—Headache—Acetazolamide—epilepsy syndrome	4.2e-05	0.000692	CcSEcCtD
Methazolamide—Urticaria—Zonisamide—epilepsy syndrome	4.2e-05	0.000691	CcSEcCtD
Methazolamide—Decreased appetite—Carbamazepine—epilepsy syndrome	4.2e-05	0.000691	CcSEcCtD
Methazolamide—Feeling abnormal—Clonazepam—epilepsy syndrome	4.19e-05	0.000691	CcSEcCtD
Methazolamide—Paraesthesia—Lamotrigine—epilepsy syndrome	4.19e-05	0.00069	CcSEcCtD
Methazolamide—Body temperature increased—Zonisamide—epilepsy syndrome	4.17e-05	0.000687	CcSEcCtD
Methazolamide—Asthenia—Fosphenytoin—epilepsy syndrome	4.17e-05	0.000686	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	4.17e-05	0.000686	CcSEcCtD
Methazolamide—Feeling abnormal—Phenytoin—epilepsy syndrome	4.17e-05	0.000686	CcSEcCtD
Methazolamide—Fatigue—Carbamazepine—epilepsy syndrome	4.16e-05	0.000685	CcSEcCtD
Methazolamide—Photosensitivity reaction—Topiramate—epilepsy syndrome	4.15e-05	0.000683	CcSEcCtD
Methazolamide—Somnolence—Lamotrigine—epilepsy syndrome	4.15e-05	0.000683	CcSEcCtD
Methazolamide—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.000682	CcSEcCtD
Methazolamide—Diarrhoea—Levetiracetam—epilepsy syndrome	4.12e-05	0.000678	CcSEcCtD
Methazolamide—Dyspepsia—Lamotrigine—epilepsy syndrome	4.11e-05	0.000676	CcSEcCtD
Methazolamide—Malaise—Valproic Acid—epilepsy syndrome	4.1e-05	0.000674	CcSEcCtD
Methazolamide—Erythema multiforme—Gabapentin—epilepsy syndrome	4.09e-05	0.000673	CcSEcCtD
Methazolamide—Vertigo—Valproic Acid—epilepsy syndrome	4.08e-05	0.000672	CcSEcCtD
Methazolamide—Leukopenia—Valproic Acid—epilepsy syndrome	4.07e-05	0.000669	CcSEcCtD
Methazolamide—Asthenia—Vigabatrin—epilepsy syndrome	4.06e-05	0.000669	CcSEcCtD
Methazolamide—Decreased appetite—Lamotrigine—epilepsy syndrome	4.05e-05	0.000668	CcSEcCtD
Methazolamide—Urticaria—Clonazepam—epilepsy syndrome	4.04e-05	0.000666	CcSEcCtD
Methazolamide—Tinnitus—Gabapentin—epilepsy syndrome	4.03e-05	0.000664	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	4.03e-05	0.000663	CcSEcCtD
Methazolamide—Body temperature increased—Clonazepam—epilepsy syndrome	4.02e-05	0.000662	CcSEcCtD
Methazolamide—Fatigue—Lamotrigine—epilepsy syndrome	4.02e-05	0.000662	CcSEcCtD
Methazolamide—Dysgeusia—Pregabalin—epilepsy syndrome	4.02e-05	0.000662	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	4.02e-05	0.000662	CcSEcCtD
Methazolamide—Urticaria—Phenytoin—epilepsy syndrome	4.02e-05	0.000661	CcSEcCtD
Methazolamide—Asthenia—Diazepam—epilepsy syndrome	4e-05	0.000658	CcSEcCtD
Methazolamide—Body temperature increased—Phenytoin—epilepsy syndrome	4e-05	0.000658	CcSEcCtD
Methazolamide—Urticaria—Oxcarbazepine—epilepsy syndrome	4e-05	0.000658	CcSEcCtD
Methazolamide—Nausea—Acetazolamide—epilepsy syndrome	3.98e-05	0.000656	CcSEcCtD
Methazolamide—Feeling abnormal—Carbamazepine—epilepsy syndrome	3.98e-05	0.000655	CcSEcCtD
Methazolamide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	3.98e-05	0.000655	CcSEcCtD
Methazolamide—Diarrhoea—Fosphenytoin—epilepsy syndrome	3.97e-05	0.000654	CcSEcCtD
Methazolamide—Vomiting—Propofol—epilepsy syndrome	3.96e-05	0.000652	CcSEcCtD
Methazolamide—Rash—Propofol—epilepsy syndrome	3.93e-05	0.000647	CcSEcCtD
Methazolamide—Dermatitis—Propofol—epilepsy syndrome	3.92e-05	0.000646	CcSEcCtD
Methazolamide—Headache—Propofol—epilepsy syndrome	3.9e-05	0.000643	CcSEcCtD
Methazolamide—Vomiting—Midazolam—epilepsy syndrome	3.88e-05	0.000638	CcSEcCtD
Methazolamide—Diarrhoea—Vigabatrin—epilepsy syndrome	3.87e-05	0.000638	CcSEcCtD
Methazolamide—Asthenia—Felbamate—epilepsy syndrome	3.87e-05	0.000637	CcSEcCtD
Methazolamide—Haematuria—Topiramate—epilepsy syndrome	3.86e-05	0.000636	CcSEcCtD
Methazolamide—Feeling abnormal—Lamotrigine—epilepsy syndrome	3.84e-05	0.000633	CcSEcCtD
Methazolamide—Rash—Midazolam—epilepsy syndrome	3.84e-05	0.000633	CcSEcCtD
Methazolamide—Dermatitis—Midazolam—epilepsy syndrome	3.84e-05	0.000632	CcSEcCtD
Methazolamide—Urticaria—Carbamazepine—epilepsy syndrome	3.83e-05	0.000631	CcSEcCtD
Methazolamide—Vomiting—Levetiracetam—epilepsy syndrome	3.83e-05	0.00063	CcSEcCtD
Methazolamide—Discomfort—Valproic Acid—epilepsy syndrome	3.82e-05	0.000629	CcSEcCtD
Methazolamide—Headache—Midazolam—epilepsy syndrome	3.82e-05	0.000629	CcSEcCtD
Methazolamide—Body temperature increased—Carbamazepine—epilepsy syndrome	3.82e-05	0.000628	CcSEcCtD
Methazolamide—Diarrhoea—Diazepam—epilepsy syndrome	3.81e-05	0.000628	CcSEcCtD
Methazolamide—Ill-defined disorder—Pregabalin—epilepsy syndrome	3.81e-05	0.000627	CcSEcCtD
Methazolamide—Rash—Levetiracetam—epilepsy syndrome	3.8e-05	0.000625	CcSEcCtD
Methazolamide—Dermatitis—Levetiracetam—epilepsy syndrome	3.79e-05	0.000624	CcSEcCtD
Methazolamide—Asthenia—Zonisamide—epilepsy syndrome	3.79e-05	0.000624	CcSEcCtD
Methazolamide—Agranulocytosis—Topiramate—epilepsy syndrome	3.78e-05	0.000623	CcSEcCtD
Methazolamide—Headache—Levetiracetam—epilepsy syndrome	3.77e-05	0.000621	CcSEcCtD
Methazolamide—Confusional state—Valproic Acid—epilepsy syndrome	3.74e-05	0.000615	CcSEcCtD
Methazolamide—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.71e-05	0.00061	CcSEcCtD
Methazolamide—Urticaria—Lamotrigine—epilepsy syndrome	3.71e-05	0.00061	CcSEcCtD
Methazolamide—Malaise—Pregabalin—epilepsy syndrome	3.7e-05	0.00061	CcSEcCtD
Methazolamide—Nausea—Propofol—epilepsy syndrome	3.7e-05	0.000609	CcSEcCtD
Methazolamide—Vomiting—Fosphenytoin—epilepsy syndrome	3.69e-05	0.000608	CcSEcCtD
Methazolamide—Diarrhoea—Felbamate—epilepsy syndrome	3.69e-05	0.000608	CcSEcCtD
Methazolamide—Vertigo—Pregabalin—epilepsy syndrome	3.69e-05	0.000607	CcSEcCtD
Methazolamide—Body temperature increased—Lamotrigine—epilepsy syndrome	3.69e-05	0.000607	CcSEcCtD
Methazolamide—Dysgeusia—Gabapentin—epilepsy syndrome	3.69e-05	0.000607	CcSEcCtD
Methazolamide—Leukopenia—Pregabalin—epilepsy syndrome	3.67e-05	0.000605	CcSEcCtD
Methazolamide—Rash—Fosphenytoin—epilepsy syndrome	3.66e-05	0.000603	CcSEcCtD
Methazolamide—Dermatitis—Fosphenytoin—epilepsy syndrome	3.66e-05	0.000602	CcSEcCtD
Methazolamide—Asthenia—Clonazepam—epilepsy syndrome	3.65e-05	0.000601	CcSEcCtD
Methazolamide—Headache—Fosphenytoin—epilepsy syndrome	3.64e-05	0.000599	CcSEcCtD
Methazolamide—Asthenia—Phenytoin—epilepsy syndrome	3.63e-05	0.000597	CcSEcCtD
Methazolamide—Nausea—Midazolam—epilepsy syndrome	3.62e-05	0.000596	CcSEcCtD
Methazolamide—Diarrhoea—Zonisamide—epilepsy syndrome	3.61e-05	0.000595	CcSEcCtD
Methazolamide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.61e-05	0.000594	CcSEcCtD
Methazolamide—Vomiting—Vigabatrin—epilepsy syndrome	3.6e-05	0.000593	CcSEcCtD
Methazolamide—Nausea—Levetiracetam—epilepsy syndrome	3.58e-05	0.000589	CcSEcCtD
Methazolamide—CYP2D6—brain—epilepsy syndrome	3.57e-05	0.00327	CbGeAlD
Methazolamide—Rash—Vigabatrin—epilepsy syndrome	3.57e-05	0.000588	CcSEcCtD
Methazolamide—Dermatitis—Vigabatrin—epilepsy syndrome	3.57e-05	0.000587	CcSEcCtD
Methazolamide—Convulsion—Pregabalin—epilepsy syndrome	3.56e-05	0.000586	CcSEcCtD
Methazolamide—Headache—Vigabatrin—epilepsy syndrome	3.55e-05	0.000584	CcSEcCtD
Methazolamide—Vomiting—Diazepam—epilepsy syndrome	3.54e-05	0.000584	CcSEcCtD
Methazolamide—Anorexia—Valproic Acid—epilepsy syndrome	3.53e-05	0.000582	CcSEcCtD
Methazolamide—Rash—Diazepam—epilepsy syndrome	3.51e-05	0.000579	CcSEcCtD
Methazolamide—Dermatitis—Diazepam—epilepsy syndrome	3.51e-05	0.000578	CcSEcCtD
Methazolamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.49e-05	0.000575	CcSEcCtD
Methazolamide—Headache—Diazepam—epilepsy syndrome	3.49e-05	0.000575	CcSEcCtD
Methazolamide—Diarrhoea—Clonazepam—epilepsy syndrome	3.48e-05	0.000573	CcSEcCtD
Methazolamide—Asthenia—Carbamazepine—epilepsy syndrome	3.46e-05	0.00057	CcSEcCtD
Methazolamide—Diarrhoea—Phenytoin—epilepsy syndrome	3.46e-05	0.00057	CcSEcCtD
Methazolamide—Discomfort—Pregabalin—epilepsy syndrome	3.45e-05	0.000569	CcSEcCtD
Methazolamide—Nausea—Fosphenytoin—epilepsy syndrome	3.45e-05	0.000568	CcSEcCtD
Methazolamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.44e-05	0.000567	CcSEcCtD
Methazolamide—Erythema multiforme—Topiramate—epilepsy syndrome	3.44e-05	0.000566	CcSEcCtD
Methazolamide—Vomiting—Felbamate—epilepsy syndrome	3.43e-05	0.000565	CcSEcCtD
Methazolamide—Rash—Felbamate—epilepsy syndrome	3.4e-05	0.00056	CcSEcCtD
Methazolamide—Dermatitis—Felbamate—epilepsy syndrome	3.4e-05	0.00056	CcSEcCtD
Methazolamide—Malaise—Gabapentin—epilepsy syndrome	3.39e-05	0.000559	CcSEcCtD
Methazolamide—Tinnitus—Topiramate—epilepsy syndrome	3.39e-05	0.000559	CcSEcCtD
Methazolamide—Vertigo—Gabapentin—epilepsy syndrome	3.38e-05	0.000557	CcSEcCtD
Methazolamide—Headache—Felbamate—epilepsy syndrome	3.38e-05	0.000556	CcSEcCtD
Methazolamide—Confusional state—Pregabalin—epilepsy syndrome	3.38e-05	0.000556	CcSEcCtD
Methazolamide—Leukopenia—Gabapentin—epilepsy syndrome	3.37e-05	0.000555	CcSEcCtD
Methazolamide—Nausea—Vigabatrin—epilepsy syndrome	3.36e-05	0.000554	CcSEcCtD
Methazolamide—Vomiting—Zonisamide—epilepsy syndrome	3.36e-05	0.000553	CcSEcCtD
Methazolamide—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.35e-05	0.000552	CcSEcCtD
Methazolamide—Asthenia—Lamotrigine—epilepsy syndrome	3.35e-05	0.000551	CcSEcCtD
Methazolamide—Rash—Zonisamide—epilepsy syndrome	3.33e-05	0.000548	CcSEcCtD
Methazolamide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.33e-05	0.000548	CcSEcCtD
Methazolamide—Dermatitis—Zonisamide—epilepsy syndrome	3.33e-05	0.000548	CcSEcCtD
Methazolamide—Nausea—Diazepam—epilepsy syndrome	3.31e-05	0.000545	CcSEcCtD
Methazolamide—Headache—Zonisamide—epilepsy syndrome	3.31e-05	0.000545	CcSEcCtD
Methazolamide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.3e-05	0.000544	CcSEcCtD
Methazolamide—Somnolence—Valproic Acid—epilepsy syndrome	3.29e-05	0.000542	CcSEcCtD
Methazolamide—Dyspepsia—Valproic Acid—epilepsy syndrome	3.26e-05	0.000537	CcSEcCtD
Methazolamide—Convulsion—Gabapentin—epilepsy syndrome	3.26e-05	0.000537	CcSEcCtD
Methazolamide—Vomiting—Clonazepam—epilepsy syndrome	3.24e-05	0.000533	CcSEcCtD
Methazolamide—Decreased appetite—Valproic Acid—epilepsy syndrome	3.22e-05	0.00053	CcSEcCtD
Methazolamide—Vomiting—Phenytoin—epilepsy syndrome	3.21e-05	0.000529	CcSEcCtD
Methazolamide—Rash—Clonazepam—epilepsy syndrome	3.21e-05	0.000528	CcSEcCtD
Methazolamide—Dermatitis—Clonazepam—epilepsy syndrome	3.21e-05	0.000528	CcSEcCtD
Methazolamide—Nausea—Felbamate—epilepsy syndrome	3.2e-05	0.000528	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.2e-05	0.000527	CcSEcCtD
Methazolamide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.2e-05	0.000526	CcSEcCtD
Methazolamide—Fatigue—Valproic Acid—epilepsy syndrome	3.2e-05	0.000526	CcSEcCtD
Methazolamide—Anorexia—Pregabalin—epilepsy syndrome	3.19e-05	0.000526	CcSEcCtD
Methazolamide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.19e-05	0.000525	CcSEcCtD
Methazolamide—Headache—Clonazepam—epilepsy syndrome	3.19e-05	0.000525	CcSEcCtD
Methazolamide—Rash—Phenytoin—epilepsy syndrome	3.19e-05	0.000525	CcSEcCtD
Methazolamide—Dermatitis—Phenytoin—epilepsy syndrome	3.18e-05	0.000524	CcSEcCtD
Methazolamide—Rash—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.000522	CcSEcCtD
Methazolamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.000522	CcSEcCtD
Methazolamide—Headache—Phenytoin—epilepsy syndrome	3.17e-05	0.000521	CcSEcCtD
Methazolamide—Discomfort—Gabapentin—epilepsy syndrome	3.17e-05	0.000521	CcSEcCtD
Methazolamide—Headache—Oxcarbazepine—epilepsy syndrome	3.15e-05	0.000519	CcSEcCtD
Methazolamide—Nausea—Zonisamide—epilepsy syndrome	3.14e-05	0.000516	CcSEcCtD
Methazolamide—Dysgeusia—Topiramate—epilepsy syndrome	3.1e-05	0.000511	CcSEcCtD
Methazolamide—Confusional state—Gabapentin—epilepsy syndrome	3.1e-05	0.00051	CcSEcCtD
Methazolamide—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.07e-05	0.000506	CcSEcCtD
Methazolamide—Vomiting—Carbamazepine—epilepsy syndrome	3.07e-05	0.000505	CcSEcCtD
Methazolamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.05e-05	0.000503	CcSEcCtD
Methazolamide—Rash—Carbamazepine—epilepsy syndrome	3.04e-05	0.000501	CcSEcCtD
Methazolamide—Dermatitis—Carbamazepine—epilepsy syndrome	3.04e-05	0.000501	CcSEcCtD
Methazolamide—Nausea—Clonazepam—epilepsy syndrome	3.02e-05	0.000498	CcSEcCtD
Methazolamide—Headache—Carbamazepine—epilepsy syndrome	3.02e-05	0.000498	CcSEcCtD
Methazolamide—Paraesthesia—Pregabalin—epilepsy syndrome	3.01e-05	0.000495	CcSEcCtD
Methazolamide—Nausea—Phenytoin—epilepsy syndrome	3e-05	0.000494	CcSEcCtD
Methazolamide—Nausea—Oxcarbazepine—epilepsy syndrome	2.99e-05	0.000492	CcSEcCtD
Methazolamide—Somnolence—Pregabalin—epilepsy syndrome	2.98e-05	0.00049	CcSEcCtD
Methazolamide—Vomiting—Lamotrigine—epilepsy syndrome	2.97e-05	0.000488	CcSEcCtD
Methazolamide—Urticaria—Valproic Acid—epilepsy syndrome	2.94e-05	0.000485	CcSEcCtD
Methazolamide—Rash—Lamotrigine—epilepsy syndrome	2.94e-05	0.000484	CcSEcCtD
Methazolamide—Ill-defined disorder—Topiramate—epilepsy syndrome	2.94e-05	0.000484	CcSEcCtD
Methazolamide—Dermatitis—Lamotrigine—epilepsy syndrome	2.94e-05	0.000484	CcSEcCtD
Methazolamide—Body temperature increased—Valproic Acid—epilepsy syndrome	2.93e-05	0.000482	CcSEcCtD
Methazolamide—Anorexia—Gabapentin—epilepsy syndrome	2.93e-05	0.000482	CcSEcCtD
Methazolamide—Headache—Lamotrigine—epilepsy syndrome	2.92e-05	0.000481	CcSEcCtD
Methazolamide—Decreased appetite—Pregabalin—epilepsy syndrome	2.91e-05	0.00048	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.89e-05	0.000476	CcSEcCtD
Methazolamide—Fatigue—Pregabalin—epilepsy syndrome	2.89e-05	0.000476	CcSEcCtD
Methazolamide—Nausea—Carbamazepine—epilepsy syndrome	2.87e-05	0.000472	CcSEcCtD
Methazolamide—Malaise—Topiramate—epilepsy syndrome	2.86e-05	0.00047	CcSEcCtD
Methazolamide—Vertigo—Topiramate—epilepsy syndrome	2.85e-05	0.000468	CcSEcCtD
Methazolamide—Leukopenia—Topiramate—epilepsy syndrome	2.84e-05	0.000467	CcSEcCtD
Methazolamide—Nausea—Lamotrigine—epilepsy syndrome	2.77e-05	0.000456	CcSEcCtD
Methazolamide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.76e-05	0.000455	CcSEcCtD
Methazolamide—Paraesthesia—Gabapentin—epilepsy syndrome	2.76e-05	0.000454	CcSEcCtD
Methazolamide—Convulsion—Topiramate—epilepsy syndrome	2.74e-05	0.000452	CcSEcCtD
Methazolamide—Somnolence—Gabapentin—epilepsy syndrome	2.73e-05	0.00045	CcSEcCtD
Methazolamide—Dyspepsia—Gabapentin—epilepsy syndrome	2.7e-05	0.000445	CcSEcCtD
Methazolamide—Decreased appetite—Gabapentin—epilepsy syndrome	2.67e-05	0.00044	CcSEcCtD
Methazolamide—Discomfort—Topiramate—epilepsy syndrome	2.66e-05	0.000439	CcSEcCtD
Methazolamide—Urticaria—Pregabalin—epilepsy syndrome	2.66e-05	0.000438	CcSEcCtD
Methazolamide—Asthenia—Valproic Acid—epilepsy syndrome	2.66e-05	0.000438	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.65e-05	0.000437	CcSEcCtD
Methazolamide—Fatigue—Gabapentin—epilepsy syndrome	2.65e-05	0.000436	CcSEcCtD
Methazolamide—Body temperature increased—Pregabalin—epilepsy syndrome	2.65e-05	0.000436	CcSEcCtD
Methazolamide—Confusional state—Topiramate—epilepsy syndrome	2.61e-05	0.000429	CcSEcCtD
Methazolamide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.54e-05	0.000418	CcSEcCtD
Methazolamide—Feeling abnormal—Gabapentin—epilepsy syndrome	2.53e-05	0.000417	CcSEcCtD
Methazolamide—Anorexia—Topiramate—epilepsy syndrome	2.46e-05	0.000406	CcSEcCtD
Methazolamide—Urticaria—Gabapentin—epilepsy syndrome	2.44e-05	0.000402	CcSEcCtD
Methazolamide—Body temperature increased—Gabapentin—epilepsy syndrome	2.43e-05	0.0004	CcSEcCtD
Methazolamide—Asthenia—Pregabalin—epilepsy syndrome	2.4e-05	0.000396	CcSEcCtD
Methazolamide—Vomiting—Valproic Acid—epilepsy syndrome	2.36e-05	0.000388	CcSEcCtD
Methazolamide—Rash—Valproic Acid—epilepsy syndrome	2.34e-05	0.000385	CcSEcCtD
Methazolamide—Dermatitis—Valproic Acid—epilepsy syndrome	2.33e-05	0.000384	CcSEcCtD
Methazolamide—Headache—Valproic Acid—epilepsy syndrome	2.32e-05	0.000382	CcSEcCtD
Methazolamide—Paraesthesia—Topiramate—epilepsy syndrome	2.32e-05	0.000382	CcSEcCtD
Methazolamide—Somnolence—Topiramate—epilepsy syndrome	2.3e-05	0.000378	CcSEcCtD
Methazolamide—Diarrhoea—Pregabalin—epilepsy syndrome	2.29e-05	0.000377	CcSEcCtD
Methazolamide—Dyspepsia—Topiramate—epilepsy syndrome	2.28e-05	0.000375	CcSEcCtD
Methazolamide—Decreased appetite—Topiramate—epilepsy syndrome	2.25e-05	0.00037	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.23e-05	0.000367	CcSEcCtD
Methazolamide—Fatigue—Topiramate—epilepsy syndrome	2.23e-05	0.000367	CcSEcCtD
Methazolamide—Asthenia—Gabapentin—epilepsy syndrome	2.2e-05	0.000363	CcSEcCtD
Methazolamide—Nausea—Valproic Acid—epilepsy syndrome	2.2e-05	0.000362	CcSEcCtD
Methazolamide—Vomiting—Pregabalin—epilepsy syndrome	2.13e-05	0.000351	CcSEcCtD
Methazolamide—Feeling abnormal—Topiramate—epilepsy syndrome	2.13e-05	0.000351	CcSEcCtD
Methazolamide—Rash—Pregabalin—epilepsy syndrome	2.11e-05	0.000348	CcSEcCtD
Methazolamide—Dermatitis—Pregabalin—epilepsy syndrome	2.11e-05	0.000348	CcSEcCtD
Methazolamide—Diarrhoea—Gabapentin—epilepsy syndrome	2.1e-05	0.000346	CcSEcCtD
Methazolamide—Headache—Pregabalin—epilepsy syndrome	2.1e-05	0.000346	CcSEcCtD
Methazolamide—Urticaria—Topiramate—epilepsy syndrome	2.05e-05	0.000338	CcSEcCtD
Methazolamide—Body temperature increased—Topiramate—epilepsy syndrome	2.04e-05	0.000336	CcSEcCtD
Methazolamide—Nausea—Pregabalin—epilepsy syndrome	1.99e-05	0.000328	CcSEcCtD
Methazolamide—Vomiting—Gabapentin—epilepsy syndrome	1.95e-05	0.000322	CcSEcCtD
Methazolamide—Rash—Gabapentin—epilepsy syndrome	1.94e-05	0.000319	CcSEcCtD
Methazolamide—Dermatitis—Gabapentin—epilepsy syndrome	1.94e-05	0.000319	CcSEcCtD
Methazolamide—Headache—Gabapentin—epilepsy syndrome	1.92e-05	0.000317	CcSEcCtD
Methazolamide—Asthenia—Topiramate—epilepsy syndrome	1.85e-05	0.000305	CcSEcCtD
Methazolamide—Nausea—Gabapentin—epilepsy syndrome	1.83e-05	0.0003	CcSEcCtD
Methazolamide—Diarrhoea—Topiramate—epilepsy syndrome	1.77e-05	0.000291	CcSEcCtD
Methazolamide—Vomiting—Topiramate—epilepsy syndrome	1.64e-05	0.000271	CcSEcCtD
Methazolamide—Rash—Topiramate—epilepsy syndrome	1.63e-05	0.000268	CcSEcCtD
Methazolamide—Dermatitis—Topiramate—epilepsy syndrome	1.63e-05	0.000268	CcSEcCtD
Methazolamide—Headache—Topiramate—epilepsy syndrome	1.62e-05	0.000267	CcSEcCtD
Methazolamide—Nausea—Topiramate—epilepsy syndrome	1.54e-05	0.000253	CcSEcCtD
Methazolamide—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	2.65e-06	7.18e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—UPB1—epilepsy syndrome	2.64e-06	7.16e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ATIC—epilepsy syndrome	2.64e-06	7.16e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NEU1—epilepsy syndrome	2.64e-06	7.16e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTGS2—epilepsy syndrome	2.64e-06	7.15e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTGS2—epilepsy syndrome	2.64e-06	7.15e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	2.64e-06	7.14e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	2.64e-06	7.14e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	2.64e-06	7.14e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	2.64e-06	7.14e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	2.64e-06	7.14e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—APOE—epilepsy syndrome	2.62e-06	7.08e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADSL—epilepsy syndrome	2.6e-06	7.04e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.58e-06	6.98e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.56e-06	6.94e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GLUL—epilepsy syndrome	2.55e-06	6.9e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	2.54e-06	6.89e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	2.5e-06	6.77e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GBE1—epilepsy syndrome	2.46e-06	6.66e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	2.46e-06	6.66e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTGS2—epilepsy syndrome	2.44e-06	6.62e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—POMC—epilepsy syndrome	2.44e-06	6.62e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ATIC—epilepsy syndrome	2.43e-06	6.59e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—UPB1—epilepsy syndrome	2.43e-06	6.59e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NEU1—epilepsy syndrome	2.43e-06	6.59e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	2.41e-06	6.53e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	2.41e-06	6.53e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	2.41e-06	6.53e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.4e-06	6.51e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AGT—epilepsy syndrome	2.35e-06	6.36e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—POMC—epilepsy syndrome	2.34e-06	6.35e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	2.34e-06	6.34e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	2.34e-06	6.33e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	2.32e-06	6.29e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	2.31e-06	6.26e-05	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.31e-06	6.25e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—APOE—epilepsy syndrome	2.3e-06	6.23e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.29e-06	6.21e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.29e-06	6.21e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.29e-06	6.21e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.29e-06	6.21e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.29e-06	6.21e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.29e-06	6.21e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AQP1—epilepsy syndrome	2.27e-06	6.15e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	2.26e-06	6.12e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GBE1—epilepsy syndrome	2.26e-06	6.12e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	2.25e-06	6.09e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—POMC—epilepsy syndrome	2.25e-06	6.09e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	2.24e-06	6.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	2.24e-06	6.07e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ALB—epilepsy syndrome	2.23e-06	6.04e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NT5E—epilepsy syndrome	2.19e-06	5.93e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALAD—epilepsy syndrome	2.19e-06	5.93e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.19e-06	5.93e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ALB—epilepsy syndrome	2.14e-06	5.79e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	2.13e-06	5.76e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	2.11e-06	5.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.1e-06	5.68e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.1e-06	5.68e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.1e-06	5.68e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.1e-06	5.68e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	2.09e-06	5.66e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	2.09e-06	5.66e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	2.07e-06	5.6e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	2.05e-06	5.56e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	2.05e-06	5.56e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	2.05e-06	5.55e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ALB—epilepsy syndrome	2.05e-06	5.55e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	2.05e-06	5.54e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	2.01e-06	5.46e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	2.01e-06	5.46e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADSL—epilepsy syndrome	2e-06	5.43e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	2e-06	5.41e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	2e-06	5.41e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—POMC—epilepsy syndrome	1.98e-06	5.35e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GLUL—epilepsy syndrome	1.96e-06	5.32e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.95e-06	5.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.95e-06	5.28e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTGS2—epilepsy syndrome	1.95e-06	5.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.94e-06	5.27e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	1.93e-06	5.23e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.92e-06	5.21e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.92e-06	5.21e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.91e-06	5.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.91e-06	5.16e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.88e-06	5.1e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTGS2—epilepsy syndrome	1.87e-06	5.06e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.86e-06	5.05e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.84e-06	4.99e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.83e-06	4.97e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.83e-06	4.95e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.81e-06	4.9e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	1.8e-06	4.89e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ALB—epilepsy syndrome	1.8e-06	4.88e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTGS2—epilepsy syndrome	1.79e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.79e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.77e-06	4.81e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.76e-06	4.76e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	1.75e-06	4.74e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.74e-06	4.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.74e-06	4.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.74e-06	4.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.74e-06	4.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.74e-06	4.71e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.68e-06	4.56e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	1.67e-06	4.53e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.66e-06	4.5e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.64e-06	4.46e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	1.63e-06	4.42e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	1.62e-06	4.39e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.61e-06	4.36e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.6e-06	4.33e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.59e-06	4.31e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.59e-06	4.31e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.59e-06	4.31e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	1.58e-06	4.29e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	1.58e-06	4.29e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTGS2—epilepsy syndrome	1.58e-06	4.27e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.53e-06	4.16e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.53e-06	4.15e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.48e-06	4e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.48e-06	4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.47e-06	4e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	1.46e-06	3.96e-05	CbGpPWpGaD
Methazolamide—CA14—Metabolism—AKT1—epilepsy syndrome	1.46e-06	3.95e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.46e-06	3.95e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.46e-06	3.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.45e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.44e-06	3.91e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.44e-06	3.91e-05	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—AKT1—epilepsy syndrome	1.42e-06	3.85e-05	CbGpPWpGaD
Methazolamide—CA6—Metabolism—AKT1—epilepsy syndrome	1.42e-06	3.85e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	1.39e-06	3.77e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.39e-06	3.76e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—BCHE—epilepsy syndrome	1.39e-06	3.76e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.35e-06	3.66e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.34e-06	3.64e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—AKT1—epilepsy syndrome	1.33e-06	3.59e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—AKT1—epilepsy syndrome	1.33e-06	3.59e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	1.32e-06	3.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.32e-06	3.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.32e-06	3.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.32e-06	3.57e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	1.31e-06	3.54e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TH—epilepsy syndrome	1.3e-06	3.53e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.29e-06	3.5e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.26e-06	3.4e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.26e-06	3.4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.25e-06	3.39e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.24e-06	3.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.23e-06	3.33e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AKT1—epilepsy syndrome	1.23e-06	3.33e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.2e-06	3.26e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.19e-06	3.22e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.18e-06	3.2e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.18e-06	3.19e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.16e-06	3.14e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.16e-06	3.14e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.15e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.15e-06	3.11e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.14e-06	3.09e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.13e-06	3.07e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.13e-06	3.07e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.13e-06	3.06e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.09e-06	2.95e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.08e-06	2.94e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.07e-06	2.91e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.07e-06	2.91e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.07e-06	2.9e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.05e-06	2.85e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.04e-06	2.83e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.03e-06	2.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.03e-06	2.79e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.02e-06	2.76e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.01e-06	2.73e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TH—epilepsy syndrome	1.01e-06	2.73e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.9e-07	2.68e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	9.88e-07	2.68e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	9.84e-07	2.67e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AKT1—epilepsy syndrome	9.8e-07	2.65e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	9.8e-07	2.65e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	9.76e-07	2.64e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GPX1—epilepsy syndrome	9.71e-07	2.63e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.52e-07	2.58e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.52e-07	2.58e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AKT1—epilepsy syndrome	9.39e-07	2.54e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	9.39e-07	2.54e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	9.31e-07	2.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	9.29e-07	2.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TH—epilepsy syndrome	9.25e-07	2.51e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	9.2e-07	2.49e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TH—epilepsy syndrome	9.17e-07	2.48e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.03e-07	2.45e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AKT1—epilepsy syndrome	9.01e-07	2.44e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AGT—epilepsy syndrome	8.51e-07	2.31e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	8.4e-07	2.27e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOE—epilepsy syndrome	8.34e-07	2.26e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAT—epilepsy syndrome	8.28e-07	2.24e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	8.06e-07	2.18e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AKT1—epilepsy syndrome	7.92e-07	2.14e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.76e-07	2.1e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.72e-07	2.09e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	7.65e-07	2.07e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAT—epilepsy syndrome	7.62e-07	2.06e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.57e-07	2.05e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAT—epilepsy syndrome	7.55e-07	2.05e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.52e-07	2.04e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	7.49e-07	2.03e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	7.41e-07	2.01e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	7.35e-07	1.99e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—POMC—epilepsy syndrome	7.17e-07	1.94e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.89e-07	1.87e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	6.83e-07	1.85e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.79e-07	1.84e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AGT—epilepsy syndrome	6.57e-07	1.78e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALB—epilepsy syndrome	6.53e-07	1.77e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.46e-07	1.75e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOE—epilepsy syndrome	6.44e-07	1.74e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.43e-07	1.74e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.14e-07	1.66e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.07e-07	1.64e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TH—epilepsy syndrome	6.05e-07	1.64e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AGT—epilepsy syndrome	6.04e-07	1.64e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AGT—epilepsy syndrome	5.99e-07	1.62e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.92e-07	1.6e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOE—epilepsy syndrome	5.87e-07	1.59e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	5.72e-07	1.55e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—POMC—epilepsy syndrome	5.53e-07	1.5e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.09e-07	1.38e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.05e-07	1.37e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—POMC—epilepsy syndrome	5.04e-07	1.37e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALB—epilepsy syndrome	5.04e-07	1.37e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.98e-07	1.35e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.85e-07	1.31e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.64e-07	1.26e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALB—epilepsy syndrome	4.6e-07	1.25e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.5e-07	1.22e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	4.41e-07	1.19e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.06e-07	1.1e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	4.02e-07	1.09e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.95e-07	1.07e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.87e-07	1.05e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.32e-07	9.01e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.03e-07	8.21e-06	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKT1—epilepsy syndrome	2.87e-07	7.78e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.65e-07	7.18e-06	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.22e-07	6e-06	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.04e-07	5.52e-06	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.02e-07	5.48e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.33e-07	3.61e-06	CbGpPWpGaD
